SyVento and OncoArendi agreement

February 18, 2026

In just one month, we will be heading to RNA Leaders Europe 2026 taking place on 18–19 March in Vienna. We’re excited to join leading experts and innovators shaping the rapidly evolving world of RNA therapeutics. SyVento BioTech will be represented by: Eliza Milewicz, SVP, Chief Commercial Officerand Dominik Lipka, Chief Technology Officer. This event […]

December 15, 2025

  Mabion S.A. and SyVento sp. z o.o. announce the signing of a Letter of Intent to establish cooperation in the manufacturing of a medicinal product. Under the planned collaboration, SyVento will provide aseptic fill and finish services for the drug product on behalf of Mabion, in pre-filled syringe (PFS) and cartridge formats. These fill […]

November 7, 2025

We are excited to announce that SyVento BioTech will be participating in the 13th mRNA Health Conference in Berlin! This annual event will take place on 11-13 November, bringing together leading experts in hasztag#mRNA science and we are proud to be part of this important dialogue. Our representatives, Dominik Lipka PhD Eng. – CTO, and […]

November 5, 2025

Join us next week at TIDES: Oligonucleotides and Peptide Therapeutics in Basel! SyVento BioTech will be represeted by Anna Michalska and Andreas Stocker who will be more than happy to discuss potential collaboration. We offer hasztag#CDMO services for preclinical and clinical drug development, GMP manufacturing and aseptic fill & finish. Our expertise includes mRNA/LNP technologies […]

October 27, 2025

As October turns into November, exciting weeks are ahead for SyVento BioTech! While we are finalizing preparations for CPHI Milan (booth #3.1H80A) we are also eagerly looking forward to hasztag#BIOEurope, taking place 3–5 November in Vienna, Austria. BIO-Europe is one of the leading partnering conferences for the global biotech and pharmaceutical industry – where innovation, […]

October 3, 2025

At the end of this month, the global pharma community will gather for CPHI Milan 2025 – and SyVento BioTech is looking forward to be part of it. We specialize in comprehensive hasztag#CDMO services for pharma and biotech innovatiors, offering preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & […]

October 1, 2025

We are glad to share that SyVento BioTech will join Nordic Life Science Days 2025 in Gothenburg on 13 – 14October. NLSDays is the key Nordic meeting point for biotech and pharma innovators – a place to exchange ideas, start conversations, and explore collaborations. You will find us at the Polish National Pavilion (PAIH) at […]

September 24, 2025

We are thrilled to announce a strategic partnership between SyVento BioTech and Kymos Group, aimed at unlocking the full potential of the CDMO and CRO services offered by both companies. By combining SyVento’s expertise in preclinical/clinical drug development, liposomal/LNP technologies and GMP manufacturing of clinical/ commercial batches with Kymos’ excellence in advanced bioanalytical and CMC […]

September 22, 2025

We are delighted to share that SyVento BioTech will be participating in the upcoming The World Vaccine Congress in Amsterdam! At SyVento BioTech, we are committed to advancing the future of vaccines and novel therapies by offering integrated services – from mRNA synthesis and liposomal/LNP formulation development to cGMP manufacturing and beyond – all with […]